In the context of hepatocellular carcinoma, AFP is particularly valuable. Many patients with HCC exhibit high levels of AFP, making it a useful tool for screening high-risk populations, such as those with chronic liver diseases like hepatitis B or cirrhosis. While not definitive on its own, a high AFP level can prompt further diagnostic testing, such as imaging studies or biopsies, to confirm the presence of cancer.
